Invention Grant
- Patent Title: Prolyl hydroxylase inhibitors
- Patent Title (中): 脯氨酰羟化酶抑制剂
-
Application No.: US14026164Application Date: 2013-09-13
-
Publication No.: US08815884B2Publication Date: 2014-08-26
- Inventor: Duke M. Fitch , Antony N. Shaw , Kenneth Wiggall
- Applicant: GlaxoSmithKline LLC
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Kathryn L. Coulter; James M. Kanagy
- Main IPC: C07D239/54
- IPC: C07D239/54 ; A61K31/515
Abstract:
The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
Public/Granted literature
- US20140024666A1 PROLYL HYDROXYLASE INHIBITORS Public/Granted day:2014-01-23
Information query
